Open

Coming up

Don't miss

Replay


LATEST SHOWS

MEDIAWATCH

Is Carla Bruni against a political comeback for Sarkozy?

Read more

DEBATE

Clone of Pakistan Protests: Democracy put the test (Part Two)

Read more

DEBATE

Pakistan Protests: Democracy put the test (Part One)

Read more

ENCORE!

The French Maestro of Soul

Read more

FOCUS

US tobacco giants want lion's share of e-cigarette business

Read more

ENCORE!

Bold and bonkers: Kate Bush is back on stage

Read more

THE INTERVIEW

Simon Serfaty, US foreign policy specialist

Read more

IN THE PAPERS

'It's a War, Stupid!'

Read more

BUSINESS DAILY

French PM calls on ECB to go further to help economy

Read more

  • US military targets Somalia's al Shabaab Islamist group

    Read more

  • French education ministry picture sparks racist abuse

    Read more

  • UN backs Iraqi request for inquiry into IS militant crimes

    Read more

  • Obama calls for higher wages amid 'revving' US economy

    Read more

  • Video: Ukraine’s children return to school as fighting rages on

    Read more

  • Americans detained in North Korea call for US help

    Read more

  • US urges Israel to reverse West Bank land seizure

    Read more

  • Lesotho PM calls for regional peacekeeping force after ‘coup’

    Read more

  • Ukrainian forces retreat from Luhansk airport after clashes

    Read more

  • Teddy Riner, France’s unstoppable judo champion

    Read more

  • Death toll rises in Paris apartment building blast

    Read more

  • Iraqi forces free Amerli in biggest victory over IS militants since June

    Read more

  • French police arrest hungry hedgehog hunters

    Read more

  • Tripoli under control of militias, says government

    Read more

  • Monaco’s Falcao leaves Ligue 1 for Man Utd

    Read more

  • Spain orders custody for parents of ill British boy

    Read more

France

French lawsuit reignites debate on contraceptive pill

Text by Charlotte BOITIAUX , Rachel HOLMAN

Latest update : 2013-01-05

France’s health and drug safety agency has said it is weighing the possibility of restricting certain types of contraceptive pills amid mounting fears over unwanted side effects, including stroke, following a high-profile lawsuit.

France’s national health and drug safety agency, the ANSM, is exploring the possibility of restricting the use of certain types of contraceptive pills amid growing public alarm over unwanted side effects.

Controversy over more recent versions of the pill began in France in mid-December when Marion Larat, 25, filed a lawsuit against both the multinational pharmaceutical company Bayer and ANSM’s general director after she suffered a debilitating stroke while taking the contraceptive pill Meliane.

While all oral contraceptives carry a warning about the risk of blood clots, a number of studies have found that more recent versions, such as Meliane, carry a higher risk than their predecessors. The European Medicines Agency has supported these findings, saying that the risk of forming an embolism is twice as high in women who use what are known as third- and fourth-generation pills.

A life turned upside down

Larat, by her own account, was a promising student with high hopes of attending one of the country’s top business schools, when her life was suddenly turned upside down in June, 2006. Unbeknownst to the then 18-year-old Larat, a clot had formed in her brain, eventually resulting in a massive stroke. After three days in a coma, Larat awoke to a harsh new reality. The next several months saw her undergo intensive physiotherapy and nine different surgeries.

Suspicions that the stroke was directly linked to Meliane were confirmed by an inquiry in June 2012, which found that the attack had taken place within three months after Larat was first prescribed the pill.

Now, nearly seven years after the stroke, Larat remains severely disabled. Her right hand, which she once used for day-to-day tasks such as writing, is no longer functional, and her ability to walk or speak is laboured.

Fear over the pill

Larat’s story quickly attracted widespread media attention in France, and just two weeks after filing her case, her lawyers announced on Saturday, December 29, that 30 other women had come forward with similar lawsuits.

As public concern over the safety of more recent versions of contraceptive pills grew, France’s government announced on Thursday that it would cease to reimburse prescription costs of third-generation pills as of March 31, instead of at the end of September as previously planned. The ANSM has also launched an inquiry reviewing health care professionals’ prescription practices, which the agency said may be responsible for the over-use of third and fourth-generation pills, despite previous warnings of possible health risks.

The ANSM also said that it was considering restricting the use of third-generation pills to only certain specialist doctors.

The government and ANSM’s reactions, however, has alarmed some who fear that in trying to resolve one public health concern, officials may be creating another.

“The general panic over this story has created a media frenzy, which could scare women from using the pill. It’s dangerous because the one major risk from all of this could be an explosion in unwanted pregnancies and abortions,” Dr. Joelle Tort-Grumbach, a Paris-based obstetrician-gynecologist, told FRANCE 24.

“I’ve already had two patients this week who have asked me if their pill is dangerous, and whether or not they should stop taking it,” Dr. Tort-Grumbach said, adding that cases like Larat’s are extremely rare. According to France’s ministry of health and social affairs, only 3-4 percent of women who use third or fourth generation pills suffer from the unwanted side effect of blood clots.

‘We have to stop demonising the pill’

While other women’s reproductive health specialists have agreed that it is important to raise awareness over the risks linked to third and fourth-generation pills, they’ve also highlighted the importance of contextualising the information.

“There’s not a single medication on the market that comes with zero risk,” Nathalie Bajos, a contraception expert at France’s National Health and Medical Research Institute, told FRANCE 24. “Even a commonplace medicine like paracetamol can lead to complications. We have to stop demonising the pill.”

For Bajos, the decision to no longer reimburse third generation pills amounts to nothing short of folly.

“There are a number of women who can’t take first or second-generation pills for whom the newer generations are better,” Bajos said, adding that women need to be better informed about all the different forms of contraception available to them. “There are very few gynecologists who present their patients with alternatives to the pill, such as IUDs [an intrauterine device], which is a very safe and effective birth control.”

Family Planning, a member organisation of the International Planned Parenthood Federation, also weighed in on the debate, issuing a statement earlier in the month criticising the government’s “ambiguous” reaction to the controversy.

“Either this generation of pills is dangerous and should be recalled from the market, or they are not… and therefore should be accessible to everyone and reimbursable. We need a clear, coherent and reassuring position on the issue,” the organisation said.

The group also called for health care professionals to be better trained on all the different forms of contraception, as well a comprehensive public awareness campaign to inform people of their options.
 

Date created : 2013-01-04

  • FRANCE

    Parisian teens handed ‘contraception chequebooks’

    Read more

COMMENT(S)